Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Roberts

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed mealC Parkinson, W M Drake, M E Roberts, et al.
Journal of Medical Microbiology|February 1, 1970
Cardiobacterium hominis endocarditisJ Midgley, S P LaPage, B A Jenkins, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 19, 2012
CCR3 induced-p42/44 MAPK activation protects against staurosporine induced-DNA fragmentation but not apoptosis in airway smooth muscle cellsL J Markwick, D Clements, M E Roberts, et al.
Animal Reproduction Science|June 14, 2000
Efficiency of spermatogenesis: a comparative approachL Johnson, D D Varner, M E Roberts, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|November 16, 2018
Regional Rural-Urban Differences in E-Cigarette Use and Reasons for Use in the United StatesElizabeth A Mumford, Frances A Stillman, Erin Tanenbaum, et al.
Marine Pollution Bulletin|August 17, 2021
Nitrogen processing by treatment wetlands in a tropical catchment dominated by agricultural landuseE Kavehei, M E Roberts, C Cadier, et al.
European Journal of Endocrinology|December 4, 2003
Insulin sensitivity and glucose tolerance improve in patients with acromegaly converted from depot octreotide to pegvisomantW M Drake, S V Rowles, M E Roberts, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 7, 2018
De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studiesR A Bray, H M Gebel, R Townsend, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 25, 2018
Posttransplant reduction in preexisting donor-specific antibody levels after belatacept- versus cyclosporine-based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT-EXTR A Bray, H M Gebel, R Townsend, et al.
The Journal of Clinical Endocrinology and Metabolism|August 24, 2006
Reductions of circulating matrix metalloproteinase 2 and vascular endothelial growth factor levels after treatment with pegvisomant in subjects with acromegalyA N Paisley, C J O'Callaghan, K C Lewandowski, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed mealC Parkinson, W M Drake, M E Roberts, et al.
Journal of Medical Microbiology|February 1, 1970
Cardiobacterium hominis endocarditisJ Midgley, S P LaPage, B A Jenkins, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 19, 2012
CCR3 induced-p42/44 MAPK activation protects against staurosporine induced-DNA fragmentation but not apoptosis in airway smooth muscle cellsL J Markwick, D Clements, M E Roberts, et al.
Animal Reproduction Science|June 14, 2000
Efficiency of spermatogenesis: a comparative approachL Johnson, D D Varner, M E Roberts, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|November 16, 2018
Regional Rural-Urban Differences in E-Cigarette Use and Reasons for Use in the United StatesElizabeth A Mumford, Frances A Stillman, Erin Tanenbaum, et al.
Marine Pollution Bulletin|August 17, 2021
Nitrogen processing by treatment wetlands in a tropical catchment dominated by agricultural landuseE Kavehei, M E Roberts, C Cadier, et al.
European Journal of Endocrinology|December 4, 2003
Insulin sensitivity and glucose tolerance improve in patients with acromegaly converted from depot octreotide to pegvisomantW M Drake, S V Rowles, M E Roberts, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 7, 2018
De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studiesR A Bray, H M Gebel, R Townsend, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 25, 2018
Posttransplant reduction in preexisting donor-specific antibody levels after belatacept- versus cyclosporine-based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT-EXTR A Bray, H M Gebel, R Townsend, et al.
The Journal of Clinical Endocrinology and Metabolism|August 24, 2006
Reductions of circulating matrix metalloproteinase 2 and vascular endothelial growth factor levels after treatment with pegvisomant in subjects with acromegalyA N Paisley, C J O'Callaghan, K C Lewandowski, et al.
Pageof 5